BRING YOUR OWN DEVICE SECURITY ISSUES
Bring your own device (BYOD) to work has gained increased popularity and is in use in many organizations. Along with this convenience for employees are some major security issues for cyber security professionals. RESOURCES Be sure to review the Learning Resources before completing this activity. Click the weekly resources link to access the resources. WEEKLY […]
Focused SOAP Note
Patient: White female, late 40s History: Major Depressive Disorder (MDD), Generalized Anxiety Disorder (GAD) Current Medications: Sertraline (Zoloft), self‑reduced dose recently; now titrating back to prior level Provider: New primary care provider in Maryland Subjective Chief Complaint: “My mood and anxiety have worsened since I reduced my medication.” History of Present Illness: Reports daily low […]
Non‑FDA‑Approved (“Off‑Label”) Nonpharmacological Treatments for Disorders in Children and Adolescents
Introduction While pharmacological interventions are often used to treat psychiatric and developmental disorders in children and adolescents, nonpharmacological treatments play a critical role in comprehensive care. Many of these interventions are considered “off‑label” in the sense that they are not formally approved by the FDA as medical treatments, but they are widely used in practice, […]
Non‑FDA‑Approved (“Off‑Label”) Pharmacological Treatments for Disorders in Children and Adolescents Detailed Study Notes
Introduction In pediatric psychiatry, many medications are prescribed off‑label, meaning they are used outside their official FDA‑approved indications. This practice is common because relatively few psychotropic medications have formal pediatric approval, yet children and adolescents experience a wide range of psychiatric and neurodevelopmental disorders. Off‑label prescribing relies on clinical evidence, expert consensus, and extrapolation from […]
FDA‑Approved Pharmacological Treatments for Disorders in Children and Adolescents
Introduction Psychiatric and neurodevelopmental disorders in children and adolescents present unique challenges for clinicians. Unlike adults, pediatric patients have ongoing brain and body development, which influences drug absorption, metabolism, and response. While many medications are prescribed “off‑label,” a smaller set of psychotropics have FDA approval (“on label”) for specific pediatric indications. These approvals are based […]